OSTEOGROW–C is OSTEOGROW in combination with tricalcium phosphate (TCP) ceramics. A compression resistant matrix (CRM) is added to enhance the rheological and biomechanical properties of the implant for use in patients with bone fracture nonunions for whom there is no biological drug therapy available.

Read more:

  • A novel autologous bone graft substitute containing rhBMP6 in autologous blood coagulum with synthetic ceramics for reconstruction of a large humerus segmental gunshot defect in a dog: The first veterinary patient to receive a novel osteoinductive therapy
    DOI: 10.1016/j.bonr.2021.100759